Lobbying · Company
Moderna
Meetings with ministers
24
In the last 12 months
0
Different ministers
12
Lobbying firms used
1
Meetings with ministers
| Date | Minister | Purpose, as published |
|---|---|---|
| 24 June 2025 | Patrick VallanceDSIT | To discuss the Life Sciences Sector Plan |
| 14 May 2025 | Ashley DaltonDHSC | To engage with vaccines stakeholders on vaccine delivery |
| 2 April 2025 | Wes StreetingDHSC | To discuss life sciences |
| 2 April 2025 | Wes StreetingDHSC | To discuss life sciences |
| 2 April 2025 | Wes StreetingDHSC | To discuss life sciences |
| 2 April 2025 | Sir Keir StarmerPrime Minister | Biopharmaceuticals CEOs Roundtable to discuss global health challenges and life sciences policy |
| 2 April 2025 | Peter KyleDSIT | Roundtable discuss issues facing life sciences in the UK, including VPAG, clincial trials, and health data |
| 2 April 2025 | Jonathan ReynoldsDBT | To discuss the policy environment for the life sciences sector in the UK |
| 2 April 2025 | Poppy GustafssonDBT | To discuss the UK life sciences commerical environment and investment in this sector |
| 2 April 2025 | Wes StreetingDHSC | To discuss life sciences |
| 2 April 2025 | Patrick VallanceDSIT | Biopharmaceutical CEO Roundtable (BCR) Ministerial Policy Roundtable |
| 27 March 2025 | Sarah JonesDBT | Discussed the life sciences sector and the Industrial Strategy |
| 27 March 2025 | Patrick VallanceDSIT | To discuss company views on the industrial strategy |
| 26 February 2025 | Sir Keir StarmerPrime Minister | Roundtable during visit to Washington to discuss UK/US business relationships including regulation, AI, defence spending, biotech and promoting the UK as an investment destination |
| 7 February 2025 | Rachel ReevesHMT | To discuss investment in the UK life sciences industry |
| 4 February 2025 | Patrick VallanceDSIT | Visit for World Cancer Day. Discussion around how the response research program improves the effectiveness of treatments. |
| 28 January 2025 | Georgia GouldCabinet Office | Chairing of the Moderna Joint Oversight Commitee that oversees government relationship with Moderna. |
| 28 January 2025 | Patrick VallanceDSIT | To discuss progress and priorities for advancing growth in the life sciences sector. |
| 18 December 2024 | Poppy GustafssonDBT | Roundtable to discuss operations in Harwell and science and technology SME investment in the UK, and associated growth opportunities |
| 16 October 2024 | Patrick VallanceDSIT | To discuss life sciences sector opportunities in the UK. |
| 16 October 2024 | Andrew GwynneDHSC | To discuss the Moderna Strategic Partnership |
| 15 October 2024 | Abena Oppong-AsareCabinet Office | Met with Moderna to discuss Moderna's Strategic Partnership with the UK Government and their involvement in the UK’s pandemic preparedness strategy. |
| 9 October 2024 | Andrew GwynneDHSC | To discuss the Moderna Strategic Partnership |
| 9 October 2024 | Jonathan ReynoldsDBT | To discuss delivering industrial and growing health resilience. |
Consultant lobbying firms
- Political Lobbying & Media Relations LimitedJuly to September 2025; October to December 2024; July to September 2024
